Variant position: 322 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 395 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human AKSLVKAGLCRRVLVQVSYA IGVAEPLSISIFTYGTSQKTE
Mouse AKSLVKAGLCRRVLVQVSYA IGVAEPLSISIFTYGTSNKTE
Rat AKSLVKAGLCRRVLVQVSYA IGVAEPLSISIFTYGTSKKTE
Bovine AKSLVKAGLCRRVLVQVSYA IGVAEPLSISIFTYGTSQKTE
Caenorhabditis elegans ATSLVKAGLAKRVLVQLSYA IGIAKPISVLVYAFGTSPLTD
Baker's yeast AKSLVAAGLCKRVQVQFSYA IGIAEPLSLHVDTYGTATKSD
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 395 S-adenosylmethionine synthase isoform type-1
Molecular mechanisms of an inborn error of methionine pathway. Methionine adenosyltransferase deficiency.
Ubagai T.; Lei K.-J.; Huang S.; Mudd S.H.; Levy H.L.; Chou J.Y.;
J. Clin. Invest. 96:1943-1947(1995)
Cited for: VARIANTS MATD ASP-55; PRO-305; MET-322 AND LEU-357;
Methionine adenosyltransferase I/III deficiency: novel mutations and clinical variations.
Chamberlin M.E.; Ubagai T.; Mudd S.H.; Thomas J.; Pao V.Y.; Nguyen T.K.; Levy H.L.; Greene C.; Freehauf C.; Chou J.Y.;
Am. J. Hum. Genet. 66:347-355(2000)
Cited for: VARIANTS MATD ASN-38; CYS-264; HIS-264; MET-322; ARG-336 AND ALA-344; CHARACTERIZATION OF VARIANTS MATD ASN-38; CYS-264; HIS-264; MET-322; ARG-336 AND ALA-344; CATALYTIC ACTIVITY; FUNCTION; PATHWAY;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.